Danish Head And Neck Cancer Group

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Feasibility of Patient Selection and Treatment of Head-neck Cancer With Proton Therapy in Denmark

Not Applicable

Active, not recruiting

Conditions: Head-and-neck Cancer

Interventions: Other: Proton radiotherapy

First Posted Date: 2022-06-21

Last Posted Date: 2022-06-21

Lead Sponsor: Danish Head and Neck Cancer Group

Target Recruit Count: 63

Registration Number: NCT05423704

Locations: 🇩🇰
Aarhus University Hospital, Aarhus, Denmark
🇩🇰
Aalborg University Hospital, Aalborg, Denmark
🇩🇰
Rigshospitalet, Copenhagen, Denmark

and more 4 locations

DAHANCA 27 Transoral Laser Microsurgery for T1a Glottic Cancer

Phase 2

Conditions: Head and Neck Squamous Cell Carcinoma
Glottic T1

Interventions: Procedure: Transoral Laser Microsurgery

First Posted Date: 2022-03-21

Last Posted Date: 2022-03-21

Lead Sponsor: Danish Head and Neck Cancer Group

Target Recruit Count: 80

Registration Number: NCT05289336

Locations: 🇩🇰
Aarhus University Hospital, Aarhus, Denmark
🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇩🇰
Aalborg University Hospital, Aalborg, Denmark

and more 2 locations

DAHANCA 35: Proton Versus Photon Therapy for Head-neck Cancer

Not Applicable

Recruiting

Conditions: Head-and-neck Cancer

Interventions: Radiation: Proton radiotherapy
Radiation: Photon radiotherapy

First Posted Date: 2020-10-29

Last Posted Date: 2020-10-29

Lead Sponsor: Danish Head and Neck Cancer Group

Target Recruit Count: 600

Registration Number: NCT04607694

Locations: 🇩🇰
Herlev Hospital, Copenhagen, Denmark
🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇩🇰
Aalborg University Hospital, Aalborg, Denmark

and more 4 locations

DAHANCA 37. Re-irradiation With Proton Radiotherapy

Not Applicable

Recruiting

Conditions: Head and Neck Neoplasms

Interventions: Radiation: Re-irradiation

First Posted Date: 2019-06-10

Last Posted Date: 2020-09-25

Lead Sponsor: Danish Head and Neck Cancer Group

Target Recruit Count: 20

Registration Number: NCT03981068

Locations: 🇩🇰
Danish Center for Particle Therapy, Aarhus, Denmark

DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC

Phase 2

Conditions: Hypoxic Radioresistance
Radiotherapy
Locally Advanced Head and Neck Cancer

Interventions: Radiation: HART-CN

First Posted Date: 2016-11-29

Last Posted Date: 2020-10-20

Lead Sponsor: Danish Head and Neck Cancer Group

Target Recruit Count: 60

Registration Number: NCT02976051

Locations: 🇩🇰
Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark

DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.

Phase 3

Conditions: Gene Profile, Gene Signature
Radiotherapy
Hypoxic Modification
Hypoxia
Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Nimorazole

First Posted Date: 2016-01-22

Last Posted Date: 2021-04-13

Lead Sponsor: Danish Head and Neck Cancer Group

Target Recruit Count: 1252

Registration Number: NCT02661152

Locations: 🇩🇰
Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark

DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole

Phase 1

Completed

Conditions: HNSCC,Larynx, Pharynx and Oral Cavity

Interventions: Radiation: 76 Gy/ 56 fx/ 10/W with cisplatin 40 mg/m2/W and nimorazole

First Posted Date: 2012-11-27

Last Posted Date: 2017-07-28

Lead Sponsor: Danish Head and Neck Cancer Group

Target Recruit Count: 31

Registration Number: NCT01733823

Locations: 🇩🇰
Odense, Odense, Odense C, Denmark
🇩🇰
Aarhus, Aarhus, Aarhus C, Denmark
🇩🇰
Aalborg, Aalborg, Denmark

and more 1 locations

DAHANCA 25B: Progressive Resistance Training as Intervention for Regaining Muscle Mass After Radiation Therapy in Patients With HNSCC

Not Applicable

Completed

Conditions: Head and Neck Cancer

Interventions: Other: Progressive Resistance Exercise Training

First Posted Date: 2012-01-13

Last Posted Date: 2016-11-29

Lead Sponsor: Danish Head and Neck Cancer Group

Target Recruit Count: 41

Registration Number: NCT01509430

Locations: 🇩🇰
Dept. of Experimental Clinical Oncology, Aarhus C, Denmark

IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck

Phase 3

Terminated

Conditions: Head and Neck Carcinoma

Interventions: Radiation: Accl. RT
Radiation: Accl. radiotherapy + Nimorazole

First Posted Date: 2012-01-11

Last Posted Date: 2016-11-25

Lead Sponsor: Danish Head and Neck Cancer Group

Target Recruit Count: 104

Registration Number: NCT01507467

Locations: 🇪🇬
Radiation Oncology Department, National Cancer Institute, Cairo, Egypt
🇵🇰
Nuclear Medicine, Oncology & Radiotherapy Institute, Radiation Oncology Department G-8/3, Islamabad, Pakistan
🇪🇪
Radiation Oncology Center, Tallin, Estonia

and more 3 locations

DAHANCA 25A: Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer Patients

Not Applicable

Completed

Conditions: Head and Neck Neoplasms

Interventions: Other: Resistance training
Dietary Supplement: Protein and creatine
Dietary Supplement: Placebo

First Posted Date: 2009-12-03

Last Posted Date: 2016-11-29

Lead Sponsor: Danish Head and Neck Cancer Group

Target Recruit Count: 30

Registration Number: NCT01025518

Locations: 🇩🇰
Dept. of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Region Midt, Denmark
🇩🇰
Dept. of Experimental Clinical Oncology, Aarhus, Denmark

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy